How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemia
- 31 August 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (8), 1006-1009
- https://doi.org/10.1016/0277-5379(91)90269-j
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in childrenCancer, 1987
- A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemiaCancer, 1987
- Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: A pilot study from April 1981Medical and Pediatric Oncology, 1986
- METHOTREXATE SYSTEMIC CLEARANCE INFLUENCES PROBABILITY OF RELAPSE IN CHILDREN WITH STANDARD-RISK ACUTE LYMPHOCYTIC LEUKAEMIAThe Lancet, 1984
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Analysis of Survival Data under the Proportional Hazards ModelInternational Statistical Review, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958